These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 17368602)
1. In reply to Tate et al. Clin Chim Acta 2007;376:30-6. Robson E; Mead G; Carr-Smith H; Bradwell A Clin Chim Acta; 2007 May; 380(1-2):247; author reply 250-1. PubMed ID: 17368602 [No Abstract] [Full Text] [Related]
2. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Tate JR; Mollee P; Dimeski G; Carter AC; Gill D Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362 [TBL] [Abstract][Full Text] [Related]
3. [Primary amyloidosis and thrombophlebitis as complications of Bence-Jones plasmacytoma (lambda type)]. Baier J; Neumann H; Grossmann R; Ricken D Med Klin (Munich); 1991 Jan; 86(1):53-7. PubMed ID: 1901936 [No Abstract] [Full Text] [Related]
4. Bence-Jones proteins and light chains of immunoglobulins (second of two parts). Solomon A N Engl J Med; 1976 Jan; 294(2):91-8. PubMed ID: 53788 [No Abstract] [Full Text] [Related]
5. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine. Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172 [TBL] [Abstract][Full Text] [Related]
6. [Purification of the Bence Jones protein from patients with myeloma]. Chaker R; Siala T Arch Inst Pasteur Tunis; 1982 Mar; 59(1):213-6. PubMed ID: 6817722 [No Abstract] [Full Text] [Related]
7. [Determination of light chains in serum]. Hansen CT; Nielsen L; Münster AM; Abildgaard N Ugeskr Laeger; 2010 Aug; 172(34):2302-5. PubMed ID: 20727297 [TBL] [Abstract][Full Text] [Related]
8. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia. Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187 [TBL] [Abstract][Full Text] [Related]
9. The clinical significance of Bence Jones proteinuria. Perry MC; Kyle RA Mayo Clin Proc; 1975 May; 50(5):234-8. PubMed ID: 1127990 [TBL] [Abstract][Full Text] [Related]
10. Proteinuria in multiple myeloma and related diseases. Ganeval D; Lacour B; Chopin N; Grünfeld JP Am J Nephrol; 1990; 10 Suppl 1():58-62. PubMed ID: 2124083 [TBL] [Abstract][Full Text] [Related]
11. Amino acid sequence of an amyloidogenic Bence Jones protein in myeloma-associated systemic amyloidosis. Tonoike H; Kametani F; Hoshi A; Shinoda T; Isobe T FEBS Lett; 1985 Jun; 185(1):139-41. PubMed ID: 3922791 [TBL] [Abstract][Full Text] [Related]
12. Serum test for assessment of patients with Bence Jones myeloma. Bradwell AR; Carr-Smith HD; Mead GP; Harvey TC; Drayson MT Lancet; 2003 Feb; 361(9356):489-91. PubMed ID: 12583950 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma]. Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965 [TBL] [Abstract][Full Text] [Related]
14. Histology and function of the kidney in marked Bence Jones paraproteinuria. Nagengast FM; Assmann KJ; Fennis JF Neth J Med; 1980; 23(1):38. PubMed ID: 6767990 [No Abstract] [Full Text] [Related]
15. [Acute terminal erythremia in a Bence-Jones myeloma patient]. Woessner S; Lafuente R; Vila X; Florensa L; Martín E Sangre (Barc); 1986; 31(4):506-7. PubMed ID: 3787420 [No Abstract] [Full Text] [Related]
16. [A lambda Bence-Jones protein with an unusual amino acid sequence]. Zlotnick A Harefuah; 1969 Nov; 77(9):399-401. PubMed ID: 5397693 [No Abstract] [Full Text] [Related]
17. [Bence-Jones proteinuria and kidney's damages]. Strada E; Battistelli L; Savazzi G Recenti Prog Med; 2008; 99(7-8):389-94. PubMed ID: 18751619 [TBL] [Abstract][Full Text] [Related]